Clinical Trial Update: Local Registration Trial in China Humalog Mix 50 [Phase 3]

View source ↗

Summary

A Phase 3 local registration trial of Humalog Mix 50 for diabetes mellitus type 1 and type 2 in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog Mix 50 (insulin lispro mix 50)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED